DAFNA Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

DAFNA Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-23,090	Closed	-$2.03M	–	93
2015 Q2	$2.03M	Sell	23,090 -310	-1%	-$26.5K	1.72%	21
2015 Q1	$1.74M	Sell	23,400 -500	-2%	-$35.3K	1.33%	20
2014 Q4	$1.34M	Sell	23,900 -13,000	-35%	-$683K	1.06%	26
2014 Q3	$1.67M	Buy	+36,900	New	+$1.54M	1.69%	16
2014 Q2	–	Sell	-12,600	Closed	-$873K	–	51
2014 Q1	$873K	Hold	12,600	–	–	0.75%	28
2013 Q4	$759K	Buy	+12,600	New	+$685K	0.78%	30

Other funds holding CLVS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

DAFNA Capital Management's CLVS Position: Q3 2015 in Review

DAFNA Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2015, closing a stake of 23,090 shares — an estimated $2.03M sold.

DAFNA Capital Management first reported a position in CLVS in Q4 2013 and held it in 6 quarters. The position peaked at $2.03M in Q2 2015. 192 funds tracked by Wall St. Rank hold CLVS as of Q3 2015.

DAFNA Capital Management reported no remaining Clovis Oncology, Inc. position as of Q3 2015 after selling out during the quarter.
DAFNA Capital Management sold 23,090 Clovis Oncology, Inc. shares in Q3 2015, an estimated $2.03M.
DAFNA Capital Management first reported a position in Clovis Oncology, Inc. in Q4 2013 and held it in 6 quarters.
DAFNA Capital Management's Clovis Oncology, Inc. position peaked at $2.03M in Q2 2015.
192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2015.

Based on DAFNA Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.